Chemotherapy-Free Treatment Shows Promise for Some Metastatic Breast Cancer Patients
In a small new study, a chemo-free regimen of four targeted therapies benefited 97% of women with HR-positive, HER2-positive metastatic breast cancer.
Health News is provided as a service to DeBerry Drugs site users by HealthDay. DeBerry Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.